NHE-1 inhibition-induced cardioprotection against ischaemia/reperfusion is associated with attenuation of the mitochondrial permeability transition

Cardiovascular Research

Volumn 77, Issue 2, 2008, Pages 416-424

  Javadov, Sabzali ^a   Choi, Angel ^a   Rajapurohitam, Venkatesh ^a   Zeidan, Asad ^a   Basnakian, Alexei G ^b   Karmazyn, Morris ^a  

^a WESTERN UNIVERSITY   (Canada)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Apoptosis; Heart; Ischaemia; Mitochondria; Reperfusion; Sodium hydrogen exchanger

Indexed keywords

APOPTOSIS INDUCING FACTOR; AVE 4890; CALCIUM; CITRATE SYNTHASE; CYTOCHROME C OXIDASE; ENDONUCLEASE G; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; SODIUM PROTON EXCHANGE PROTEIN 1; SODIUM PROTON EXCHANGE PROTEIN 1 INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; ENZYME ACTIVITY; ENZYME RELEASE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; ISOLATED HEART; LIGHT SCATTERING; MALE; MITOCHONDRIAL PERMEABILITY; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; APOPTOSIS INDUCING FACTOR; CALCIUM; CITRATE (SI)-SYNTHASE; ENDODEOXYRIBONUCLEASES; MALE; MITOCHONDRIA, HEART; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MYOCARDIAL REPERFUSION INJURY; OXYGEN CONSUMPTION; RATS; RATS, SPRAGUE-DAWLEY; SODIUM-HYDROGEN ANTIPORTER;

EID: 38849122011     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvm039     Document Type: Article

References (36)

1. + exchanger: a potential therapeutic target for the prevention of myocardial ischaemic and reperfusion injury and attenuation of postinfarction heart failure. Drugs 2001;61:375-389.
2. + exchange. Am J Physiol 1988;255:H608-H615.
3. Avkiran M, Marber MS. Na(+)/H(+) exchange inhibitors for cardioprotective therapy: progress, problems and prospects. J Am Coll Cardiol 2002;39:747-753.
4. Gumina RJ, Gross GJ. If ischaemic preconditioning is the gold standard, has a platinum standard of cardioprotection arrived? Comparison with NHE inhibition. J Thromb Thrombolysis 1999;8:39-44.
5. Haist JV, Hirst CN, Karmazyn M. Effective protection by NHE-1 inhibition in ischaemic and reperfused heart under preconditioning blockade. Am J Physiol Heart Circ Physiol 2003;284:H798-H803.
6. Javadov S, Karmazyn M. Mitochondrial permeability transition pore opening as an endpoint to initiate cell death and as a putative target for cardioprotection. Cell Physiol Biochem 2007;20:1-22.
7. Di Lisa F, Bernardi P. Mitochondria and ischaemia-reperfusion injury of the heart: fixing a hole. Cardiovasc Res 2006;70:191-199.
8. Regula KM, Kirshenbaum LA. Apoptosis of ventricular myocytes: a means to an end. J Mol Cell Cardiol 2005;38:3-13.
9. Honda HM, Korge P, Weiss JN. Mitochondria and ischaemia/reperfusion injury. Ann NY Acad Sci 2005;1047:248-258.
10. Zamzami N, Susin SA, Marchetti P, Hirsch T, Gomez-Monterrey I, Castedo M et al. Mitochondrial control of nuclear apoptosis. J Exp Med 1996;183:1533-1544.
11. Javadov S, Huang C, Kirshenbaum L, Karmazyn M. NHE-1 inhibition improves impaired mitochondrial permeability transition and respiratory function during postinfarction remodelling in the rat. J Mol Cell Cardiol 2005;38:135-143.
12. Hohorst HJ. L-(+)-Lactate. In: Bergmeyer HU ed. Methods of Enzymatic Analysis. New York: Academic Press; 1963. p215-219.
13. Griffiths EJ, Halestrap AP. Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion. Biochem J 1995;307:93-98.
14. Srere PA. Citrate synthase. Methods Enzymol 1969;13:3-11.
15. Halestrap AP, Woodfield KY, Connern CP. Oxidative stress, thiol reagents, and membrane potential modulate the mitochondrial permeability transition by affecting nucleotide binding to the adenine nucleotide translocase. J Biol Chem 1997;272:3346-3354.
16. Yin X, Apostolov EO, Shah SV, Wang X, Bogdanov K, Buzder T et al. Induction of renal endonuclease G by cisplatin is reduced in DNase I-deficient mice. J Am Soc Nephrol 2007;18:2544-2553.
17. Javadov S, Purdham DM, Zeidan A, Karmazyn M. NHE-1 inhibition improves cardiac mitochondrial function through regulation of mitochondrial biogenesis during postinfarction remodeling. Am J Physiol Heart Circ Physiol 2006;291:H1722-H1730.
18. + overload in ischaemic/reperfused rat hearts. J Cardiovasc Pharmacol 2002;39:569-575.
19. 2+] and myocardial damage after cold ischaemia. J Cardiovasc Pharmacol 2003;41:686-698.
20. + exchanger. Eur J Pharmacol 2006;535:220-227.
21. + exchange inhibitor, inhibits the mitochondrial death pathway. Circulation 2003;108:2275-2281.
22. + exchanger in hypoxia/re-oxygenation- induced neonatal rat cardiomyocyte apoptosis. Eur J Pharmacol 2004;486:121-131.
23. + exchanger in reoxygenation-induced cardiomyocyte injury. Cardiovasc Res 2001;51:241-250.
24. Stromer H, de Groot MC, Horn M, Faul C, Leupold A, Morgan JP et al. Na(+)/H(+) exchange inhibition with HOE642 improves postischaemic recovery due to attenuation of Ca(2+) overload and prolonged acidosis on reperfusion. Circulation 2000;101:2749-2755.
25. i in rat hearts explain its lack of cardioprotection. Cardiovasc Res 2004;61:522-529.
26. Kerr PM, Suleiman MS, Halestrap AP. Reversal of permeability transition during recovery of hearts from ischaemia and its enhancement by pyruvate. Am J Physiol 1999;276:H496-H502.
27. + exchanger isoform 1 inhibition is mediated by reduced mitogen-activated protein kinase activation secondary to improved mitochondrial integrity and decreased generation of mitochondrial-derived reactive oxygen species. J Pharmacol Exp Ther 2006;317:1036-1043.
28. + exchange inhibitors on cardiac function and apoptosis in guinea-pig ischaemia-reperfused hearts. Eur J Pharmacol 2004;503:109-122.
29. Ruiz-Meana M, Garcia-Dorado D, Pina P, Inserte J, Agullo L, Soler-Soler J. Cariporide preserves mitochondrial proton gradient and delays ATP depletion in cardiomyocytes during ischaemic conditions. Am J Physiol Heart Circ Physiol 2003;285:H999-H1006.
30. + exchange inhibition against ischaemia/reperfusion injury. J Am Coll Cardiol 2001;37:957-963.
31. ATP channel opener diazoxide. J Mol Cell Cardiol 2004;37:1063-1067.
32. Arnoult D, Gaume B, Karbowski M, Sharpe JC, Cecconi F, Youle RJ. Mitochondrial release of AIF and EndoG requires caspase activation downstream of Bax/Bak-mediated permeabilization. EMBO J 2003;22:4385-4399.
33. David KK, Sasaki M, Yu SW, Dawson TM, Dawson VL. EndoG is dispensable in embryogenesis and apoptosis. Cell Death Differ 2006;13:1147-1155.
34. Liu J, Shen HM, Ong CN. Role of intracellular thiol depletion, mitochondrial dysfunction and reactive oxygen species in Salvia miltiorrhizainduced apoptosis in human hepatoma HepG2 cells. Life Sci. 2001;69:1833-1850.
35. Yang Y, Zhao S, Song J. Caspase-dependent apoptosis and -independent poly(ADP-ribose) polymerase cleavage induced by transforming growth factor beta1. Int J Biochem Cell Biol 2004;36:223-234.
36. Ohta T, Eguchi R, Suzuki A, Miyakaze S, Ayuzawa R, Kaji K. Hypoxia-induced apoptosis and tube breakdown are regulated by p38 MAPK but not by caspase cascade in an in vitro capillary model composed of human endothelial cells. J Cell Physiol 2007;211:673-681.